109 related articles for article (PubMed ID: 10706022)
1. Ocular motor abnormalities in Gaucher disease.
Harris CM; Taylor DS; Vellodi A
Neuropediatrics; 1999 Dec; 30(6):289-93. PubMed ID: 10706022
[TBL] [Abstract][Full Text] [Related]
2. Neuroradiological and eye movement correlates in children with intermittent saccade failure: "ocular motor apraxia".
Shawkat FS; Kingsley D; Kendall B; Russell-Eggitt I; Taylor DS; Harris CM
Neuropediatrics; 1995 Dec; 26(6):298-305. PubMed ID: 8719744
[TBL] [Abstract][Full Text] [Related]
3. Type 3 Gaucher's disease in a three-year-old child: saccadic eye movements analysis.
Accardo A; Bembi B; Pensiero S; Perissutti P
J AAPOS; 2005 Oct; 9(5):501-3. PubMed ID: 16213406
[TBL] [Abstract][Full Text] [Related]
4. Intermittent horizontal saccade failure ('ocular motor apraxia') in children.
Harris CM; Shawkat F; Russell-Eggitt I; Wilson J; Taylor D
Br J Ophthalmol; 1996 Feb; 80(2):151-8. PubMed ID: 8814747
[TBL] [Abstract][Full Text] [Related]
5. The role of ERG/VEP and eye movement recordings in children with ocular motor apraxia.
Shawkat FS; Harris CM; Taylor DS; Kriss A
Eye (Lond); 1996; 10 ( Pt 1)():53-60. PubMed ID: 8763304
[TBL] [Abstract][Full Text] [Related]
6. Audiometric abnormalities in children with Gaucher disease type 3.
Bamiou DE; Campbell P; Liasis A; Page J; Sirimanna T; Boyd S; Vellodi A; Harris C
Neuropediatrics; 2001 Jun; 32(3):136-41. PubMed ID: 11521209
[TBL] [Abstract][Full Text] [Related]
7. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
Drelichman G; Ponce E; Basack N; Freigeiro D; Aversa L; Graciela E; Kohan R
J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
[TBL] [Abstract][Full Text] [Related]
8. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
Kaplan P; Andersson HC; Kacena KA; Yee JD
Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
[TBL] [Abstract][Full Text] [Related]
9. Abnormal vertical optokinetic nystagmus in infants and children.
Garbutt S; Harris CM
Br J Ophthalmol; 2000 May; 84(5):451-5. PubMed ID: 10781506
[TBL] [Abstract][Full Text] [Related]
10. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
11. Clinical and enzyme studies in Gaucher disease.
Kaur M; Kabra M; Kher A; Naik G; Bharucha BA; Verma IC
Indian Pediatr; 1996 Sep; 33(9):735-8. PubMed ID: 9057400
[TBL] [Abstract][Full Text] [Related]
12. [Eye movement abnormalities as a sign for the diagnosis in Niemann-Pick disease type C].
Lengyel D; Weissert M; Schmid L; Gottlob I
Klin Monbl Augenheilkd; 1999 Jan; 214(1):50-2. PubMed ID: 10198883
[TBL] [Abstract][Full Text] [Related]
13. Novel hyperkinetic dystonia-like manifestation and neurological disease course of Swedish Gaucher patients.
Machaczka M; Paucar M; Björkvall CK; Smith NJC; Cox TM; Forsgren L; Svenningsson P
Blood Cells Mol Dis; 2018 Feb; 68():86-92. PubMed ID: 27789132
[TBL] [Abstract][Full Text] [Related]
14. Eye movements in a familial vestibulocerebellar disorder.
Harris CM; Walker J; Shawkat F; Wilson J; Russell-Eggitt I
Neuropediatrics; 1993 Jun; 24(3):117-22. PubMed ID: 8355816
[TBL] [Abstract][Full Text] [Related]
15. Coagulation abnormalities in type 1 Gaucher disease in children.
Deghady A; Marzouk I; El-Shayeb A; Wali Y
Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
[TBL] [Abstract][Full Text] [Related]
16. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
Erikson A
Acta Paediatr Scand Suppl; 1986; 326():1-42. PubMed ID: 3296644
[TBL] [Abstract][Full Text] [Related]
17. Saccade testing in the diagnosis and treatment of type 3 Gaucher disease.
Pensiero S; Accardo A; Pittis MG; Ciana G; Bembi B; Perissutti P
Neurology; 2005 Dec; 65(11):1837. PubMed ID: 16344538
[No Abstract] [Full Text] [Related]
18. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
Pastores GM; Barnett NL; Kolodny EH
Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
[TBL] [Abstract][Full Text] [Related]
19. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of pediatric ocular myasthenia gravis.
Ortiz S; Borchert M
Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
